Back to search

United Kingdom· GB-APID-4083711000001101

Colestid Orange 5g granules sachets

A colestipol product containing colestipol, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 7 of our 19 countries.

ATC C10AC02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedColestid Orange 5g granules sachetsATCC10AC02REGISTER NO.GB-APID-4083711000001…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Colestipol is registered in 7 of 19 countries.

Countries holding a registration under ATC C10AC02 (colestipol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 5 of them publish a price we can compare per daily dose

Colestipol · ATC C10AC02

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Colestipol
Manufacturer
Pfizer Ltd
Country
United Kingdom (GB)
ATC code
C10AC02
ATC class
Colestipol
Defined daily dose
20 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5012882001964
  • gtin
    5013457025354

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for colestipol.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colestipol · interactions on record

70 records

  • 3 severe
  • 54 moderate
  • 8 minor

Most severe, free to view

  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • TeriflunomideL04AK02severe
  • Chenodeoxycholic acidA05AA01moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colestipol in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colestipol products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b1cf1a02-9422-4f96-9683-7de6d7f8ee20
GET /v1/drugs/b1cf1a02-9422-4f96-9683-7de6d7f8ee20?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4083711000001101",
  "desc": "Colestid Orange 5g granules sachets (Pfizer Ltd)",
  "form": "Granules for oral suspension",
  "vpid": "4090511000001101",
  "source": "dmd",
  "vtm_id": "775369008",
  "strength": "5 gram",
  "substance": "Colestipol",
  "ingredient": "Colestipol hydrochloride",
  "supplier_code": "2082201000001106"
}

See everything about colestipol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.